The DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.
Inflammation as a Driver of Clonal Evolution in Myeloproliferative Neoplasm
Abstract
Our understanding of inflammation’s role in the pathogenesis of myeloproliferative neoplasm (MPN) is evolving. The impact of chronic inflammation, a characteristic feature of MPN, likely goes far beyond its role as a driver of constitutional symptoms. An inflammatory response to the neoplastic clone may be responsible for some pathologic aspects of MPN. Moreover, JAK2V617F mutated hematopoietic stem and progenitor cells are resistant to inflammation, and this gives the neoplastic clone a selective advantage allowing for its clonal expansion. Because inflammation plays a central role in MPN inflammation is a logical therapeutic target in MPN.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Given that emerging evidence suggests that inflammation very likely plays a causative role in the pathology of MPN (Fleischman, 2015; Koschmieder et al., 2016)”
From Inhibition of Inflammatory Signaling in Tet2 Mutant Preleukemic Cells Mitigates Stress-Induced Abnormalities and Clonal Hematopoiesis (2018) · cites this paper as Fleischman, 2015
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Age-related clonal hematopoiesis associated with adverse outcomes
Jaiswal, S., Fontanillas, P., Flannick, J., Manning, A., Grauman, P. V., Mar, B. G., Lindsley, R. C., Mermel, C. H., Burtt, N., Chavez, A., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1408617 · Cited by 4,841
Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence
Genovese, G., Kähler, A. K., Handsaker, R. E., Lindberg, J., Rose, S. A., Bakhoum, S. F., Chambert, K., Mick, E., Neale, B. M., Fromer, M., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1409405 · Cited by 3,531
Age-related mutations associated with clonal hematopoietic expansion and malignancies
Xie, M., Lu, C., Wang, J., McLellan, M. D., Johnson, K. J., Wendl, M. C., McMichael, J. F., Schmidt, H. K., Yellapantula, V., Miller, C. A., et al. (2014) · Nature Medicine · doi:10.1038/nm.3733 · Cited by 1,874
Safety and Efficacy of INCB018424, a JAK1 and JAK2 Inhibitor, in Myelofibrosis
Verstovsek, S., Kantarjian, H., Mesa, R. A., Pardanani, A. D., Cortes-Franco, J., Thomas, D. A., Estrov, Z., Fridman, J. S., Bradley, E. C., Erickson-Viitanen, S., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1002028 · Cited by 1,164
Quintás-Cardama, A., Vaddi, K., Liu, P., Manshouri, T., Li, J., Scherle, P. A., Caulder, E., Wen, X., Li, Y., Waeltz, P., et al. (2010) · Blood · doi:10.1182/blood-2009-04-214957 · Cited by 843
Exit from dormancy provokes DNA-damage-induced attrition in haematopoietic stem cells
Walter, D., Lier, A., Geiselhart, A., Thalheimer, F. B., Huntscha, S., Sobotta, M. C., Moehrle, B., Brocks, D., Bayindir, I., Kaschutnig, P., et al. (2015) · Nature · doi:10.1038/nature14131 · Cited by 619
Clark, J. D., Flanagan, M. E., & Telliez, J.-B. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm401490p · Cited by 601
CD169 + macrophages provide a niche promoting erythropoiesis under homeostasis and stress
Chow, A., Huggins, M., Ahmed, J., Hashimoto, D., Lucas, D., Kunisaki, Y., Pinho, S., Leboeuf, M., Noizat, C., van Rooijen, N., et al. (2013) · Nature Medicine · doi:10.1038/nm.3057 · Cited by 433
Cell-fate conversion of lymphoid-committed progenitors by instructive actions of cytokines
Kondo, M., Scherer, D. C., Miyamoto, T., King, A. G., Akashi, K., Sugamura, K., & Weissman, I. L. (2000) · Nature · doi:10.1038/35030112 · Cited by 382
Chronic exposure to a TLR ligand injures hematopoietic stem cells
Esplin, B. L., Shimazu, T., Welner, R. S., Garrett, K. P., Nie, L., Zhang, Q., Humphrey, M. B., Yang, Q., Borghesi, L. A., & Kincade, P. W. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1003438 · Cited by 319
Kleppe, M., Kwak, M., Koppikar, P., Riester, M., Keller, M., Bastian, L., Hricik, T., Bhagwat, N., McKenney, A. S., Papalexi, E., et al. (2015) · Cancer Discovery · doi:10.1158/2159-8290.cd-14-0736 · Cited by 315
Impaired Expression of the Thrombopoietin Receptor by Platelets from Patients with Polycythemia Vera
Moliterno, A. R., Hankins, W. D., & Spivak, J. L. (1998) · New England Journal of Medicine · doi:10.1056/nejm199802263380903 · Cited by 302
Hasselbalch, H. C. (2012) · Blood · doi:10.1182/blood-2011-11-394775 · Cited by 300
TNFα facilitates clonal expansion of JAK2V617F positive cells in myeloproliferative neoplasms
Fleischman, A. G., Aichberger, K. J., Luty, S. B., Bumm, T. G., Petersen, C. L., Doratotaj, S., Vasudevan, K. B., LaTocha, D. H., Yang, F., Press, R. D., et al. (2011) · Blood · doi:10.1182/blood-2011-04-348144 · Cited by 292
Self-citationHasselbalch, H. C. (2013) · Leukemia Research · doi:10.1016/j.leukres.2012.10.020 · Cited by 254
Macrophages support pathological erythropoiesis in polycythemia vera and β-thalassemia
Ramos, P., Casu, C., Gardenghi, S., Breda, L., Crielaard, B. J., Guy, E., Marongiu, M. F., Gupta, R., Levine, R. L., Abdel-Wahab, O., et al. (2013) · Nature Medicine · doi:10.1038/nm.3126 · Cited by 227
A role for reactive oxygen species in JAK2V617F myeloproliferative neoplasm progression
Marty, C., Lacout, C., Droin, N. M., Couedic, J. L., Ribrag, V., Solary, É., Vainchenker, W., Villeval, J., & Plo, I. (2013) · Leukemia · doi:10.1038/leu.2013.102 · Cited by 210
Autoimmunity and the risk of myeloproliferative neoplasms
Kristinsson, S. Y., Landgren, O., Samuelsson, J., Björkholm, M., & Goldin, L. R. (2010) · Haematologica · doi:10.3324/haematol.2009.020412 · Cited by 200
Bersenev, A., Wu, C., Balcerek, J., & Tong, W. (2008) · Journal of Clinical Investigation · doi:10.1172/jci35808 · Cited by 194
TYK2–STAT1–BCL2 Pathway Dependence in T-cell Acute Lymphoblastic Leukemia
Sanda, T., Tyner, J. W., Gutiérrez, A., Ngo, V. N., Glover, J., Chang, B. H., Yost, A., Ma, W., Fleischman, A. G., Zhou, W., et al. (2013) · Cancer Discovery · doi:10.1158/2159-8290.cd-12-0504 · Cited by 146
Self-citationSiewe, L., Bollati‐Fogolín, M., Wickenhauser, C., Krieg, T. M., Müller, W., & Roers, A. (2006) · European Journal of Immunology · doi:10.1002/eji.200636012 · Cited by 132
Fleischman, A. G., Maxson, J. E., Luty, S. B., Agarwal, A., Royer, L. R., Abel, M. L., MacManiman, J. D., Loriaux, M., Druker, B. J., & Tyner, J. W. (2013) · Blood · doi:10.1182/blood-2013-06-509976 · Cited by 118
Self-citationInflammatory ROS promote and cooperate with the Fanconi anemia mutation for hematopoietic senescence
Zhang, X., Sejas, D. P., Qiu, Y., Williams, D. A., & Pang, Q. (2007) · Journal of Cell Science · doi:10.1242/jcs.003152 · Cited by 115
King, A. G., Kondo, M., Scherer, D. C., & Weissman, I. L. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.072087899 · Cited by 115
Emerging role of interleukin‐33 in autoimmune diseases
Pei, C., Barbour, M., Fairlie‐Clarke, K. J., Allan, D., Mu, R., & Jiang, H. (2013) · Immunology · doi:10.1111/imm.12174 · Cited by 111
Posttranslational Processing of the Thrombopoietin Receptor Is Impaired in Polycythemia Vera
Moliterno, A. R., & Spivak, J. L. (1999) · Blood · doi:10.1182/blood.v94.8.2555.420k14_2555_2561 · Cited by 104
Bousse‐Kerdilès, M. L., & Martyré, M. C. (1999) · Annals of Hematology · doi:10.1007/s002770050595 · Cited by 99
IL-33 signaling contributes to the pathogenesis of myeloproliferative neoplasms
Mager, L. F., Riether, C., Schürch, C. M., Banz, Y., Wasmer, M.-H., Stuber, R., Theocharides, A. P. A., Li, X., Xia, Y., Saito, H., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci77347 · Cited by 95
An Immune Dysregulation in MPN
Barosi, G. (2014) · Current Hematologic Malignancy Reports · doi:10.1007/s11899-014-0227-0 · Cited by 93
Sangkhae, V., Etheridge, S. L., Kaushansky, K., & Hitchcock, I. S. (2014) · Blood · doi:10.1182/blood-2014-07-587238 · Cited by 90
on behalf of the Associazione Italiana per la Ricerca sul Cancro Gruppo Italiano Malattie Mieloproliferative (AGIMM) Investigators, Vannucchi, A. M., Rotunno, G., Bartalucci, N., Raugei, G., Carrai, V., Balliu, M., Mannarelli, C., Pacilli, A., Calabresi, L., et al. (2014) · Leukemia · doi:10.1038/leu.2014.100 · Cited by 86
Lü, M., Xia, L., Liu, Y., Hochman, T., Bizzari, L., Aruch, D. B., Lew, J., Weinberg, R. S., Goldberg, J. D., & Hoffman, R. (2015) · Blood · doi:10.1182/blood-2014-12-618595 · Cited by 81
Lymphocyte development from hematopoietic stem cells
Kondo, M., Scherer, D. C., King, A. G., Manz, M. G., & Weissman, I. L. (2001) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(00)00227-6 · Cited by 74
Abnormal immunity and stem/progenitor cells in acquired aplastic anemia
Li, J., Zheng, C. L., & Han, Z. (2010) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2009.12.001 · Cited by 68
Boissinot, M., Cleyrat, C., Vilaine, M., Jacques, Y., Corre, I., & Hermouet, S. (2010) · Oncogene · doi:10.1038/onc.2010.479 · Cited by 64
Pecquet, C., Diaconu, C. C., Staerk, J., Girardot, M., Marty, C., Royer, Y., Defour, J., Dusa, A., Besancenot, R., Giraudier, S., et al. (2012) · Blood · doi:10.1182/blood-2011-08-372524 · Cited by 56
Kagoya, Y., Yoshimi, A., Tsuruta-Kishino, T., Arai, S., Satoh, T., Akira, S., & Kurokawa, M. (2014) · Blood · doi:10.1182/blood-2014-04-570572 · Cited by 56
Desterke, C., Bilhou‐Nabera, C., Guerton, B., Martinaud, C., Tonetti, C., Clay, D., Guglielmelli, P., Vannucchi, A. M., Bordessoule, D., Hasselbalch, H. C., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-1731 · Cited by 55
Cytokines and adhesion molecules in patients with polymyalgia rheumatica
Uddhammar, A., Sundqvist, K., Ellis, B., & Rantapää‐Dahlqvist, S. (1998) · Lara D. Veeken · doi:10.1093/rheumatology/37.7.766 · Cited by 50
Pieri, L., Pancrazzi, A., Pacilli, A., Rabuzzi, C., Rotunno, G., Fanelli, T., Guglielmelli, P., Fjerza, R., Paoli, C., Verstovšek, S., et al. (2015) · Blood · doi:10.1182/blood-2015-01-624536 · Cited by 48
The Thrombopoietin/MPL pathway in hematopoiesis and leukemogenesis
Chou, F., & Mulloy, J. C. (2011) · Journal of Cellular Biochemistry · doi:10.1002/jcb.23089 · Cited by 44
BCR-ABL1 promotes leukemia by converting p27 into a cytoplasmic oncoprotein
Agarwal, A., MacKenzie, R. J., Besson, A., Jeng, S., Carey, A., LaTocha, D. H., Fleischman, A. G., Duquesnes, N., Eide, C. A., Vasudevan, K. B., et al. (2014) · Blood · doi:10.1182/blood-2013-04-497040 · Cited by 31
Self-citationExamination of the Role of DNA Polymerase Proofreading in the Mutator Effect of Miscoding tRNAs
Slupska, M. M., King, A. G., Lu, L. I., Lin, R. H., Mao, E. F., Lackey, C. A., Chiang, J., Baikalov, C., & Miller, J. H. (1998) · Journal of Bacteriology · doi:10.1128/jb.180.21.5712-5717.1998 · Cited by 29
The stem cell fitness landscape and pathways of molecular leukemogenesis
Bagby, G. C. (2010) · Frontiers in Bioscience-Scholar · doi:10.2741/s167 · Cited by 20
Corre, I., Pineau, D., Boissinot, M., & Hermouet, S. (2005) · Experimental Hematology · doi:10.1016/j.exphem.2005.07.002 · Cited by 18
A novel thrombopoietin signaling defect in polycythemia vera platelets
Moliterno, A. R., Siebel, K. E., Sun, A. Y., Hankins, W. D., & Spivak, J. L. (1998) · Stem Cells · doi:10.1002/stem.5530160721 · Cited by 18
Barosi, G., Magrini, U., & Gale, R. P. (2010) · Leukemia Research · doi:10.1016/j.leukres.2010.05.010 · Cited by 16
Zhang, J., Fleischman, A. G., Wodarz, D., & Komarova, N. L. (2016) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2017.05.012 · Cited by 16
Self-citationChronic inflammation: is it the driver or is it paving the road for malignant transformation?
Afrasiabi, K., Zhou, Y., & Fleischman, A. G. (2015) · Genes & Cancer · doi:10.18632/genesandcancer.64 · Cited by 12
Self-citationTeofili, L., Giona, F., Martini, M., Torti, L., Cenci, T., Foà, R., Leone, G. G. M., & Larocca, L. M. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2010.29.0387 · Cited by 10
Selective Janus associated kinase 1 inhibition as a therapeutic target in myelofibrosis
Mascarenhas, J. O. (2015) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428194.2015.1004670 · Cited by 10
Rozenova, K., Jiang, J., Donaghy, R., Aressy, B., Greenberg, R. A., & Tong, W. (2015) · Blood · doi:10.1182/blood-2014-07-588145 · Cited by 9
Brooks, S. A., Luty, S. B., Lai, H. Y., Morse, S. J., Nguyen, T. K., Royer, L. R., Agarwal, A., Druker, B. J., & Fleischman, A. G. (2015) · Experimental Hematology · doi:10.1016/j.exphem.2015.09.006 · Cited by 7
Self-citationTransduction-Transplantation Mouse Model of Myeloproliferative Neoplasm
Nguyen, T. K., Morse, S. J., & Fleischman, A. G. (2016) · Journal of Visualized Experiments · doi:10.3791/54624 · Cited by 7
Self-citationNguyen, T. K., Tata, P. V., Brooks, S. A., Jena, N., Morse, S. J., Liu, Z., Lai, H. Y., Rezk, S. A., Etten, R. A. V., & Fleischman, A. G. (2016) · Blood · doi:10.1182/blood.v128.22.635.635 · Cited by 6
Self-citationAgarwal, A., Fleischman, A. G., Petersen, C. L., Loriaux, M., Woltjer, R. L., Druker, B. J., & Deininger, M. W. (2010) · Blood · doi:10.1182/blood.v116.21.3389.3389 · Cited by 4
Self-citationFleischman, A. G., & Tyner, J. W. (2012) · Blood · doi:10.1182/blood-2012-03-417261 · Cited by 3
Self-citationFleischman, A. G., Luty, S. B., Garbati, M. R., Edmiston, J. B., Royer, L. R., LaTocha, D. H., Bagby, G. C., & Druker, B. J. (2013) · Blood · doi:10.1182/blood.v122.21.4097.4097 · Cited by 3
Self-citationSame mutation, different allele
Aichberger, K. J., Fleischman, A. G., & Deininger, M. W. (2009) · Blood · doi:10.1182/blood-2009-07-229906 · Cited by 2
Self-citationCSF3R T618I Mouse Bone Marrow Transplant Model Of Neutrophilic Leukemia
Maxson, J. E., Fleischman, A. G., Luty, S. B., Royer, L. R., Agarwal, A., Loriaux, M., Druker, B. J., & Tyner, J. W. (2013) · Blood · doi:10.1182/blood.v122.21.223.223 · Cited by 2
Self-citationJak2 V617F Induced TNF Resistance as a Mechanism of Clonal Expansion In Myeloproliferative Neoplasm
Fleischman, A. G., Aichberger, K. J., Petersen, C. L., Doratotaj, S., Bumm, T. G. P., Pahl, H. L., Druker, B. J., & Deininger, M. W. (2010) · Blood · doi:10.1182/blood.v116.21.795.795 · Cited by 1
Self-citationMaxson, J. E., Gotlib, J. R., Fleischman, A. G., Eide, C. A., Bottomly, D., Wilmot, B., McWeeney, S. K., Tognon, C. E., Loriaux, M., Druker, B. J., et al. (2012) · Blood · doi:10.1182/blood.v120.21.2412.2412 · Cited by 1
Self-citation
Cited by
Cai, Z., Kotzin, J. J., Ramdas, B., Chen, S., Nelanuthala, S., Palam, L. R., Pandey, R., Mali, R. S., Liu, Y., Kelley, M. R., et al. (2018) · Cell Stem Cell · doi:10.1016/j.stem.2018.10.013 · Cited by 394
Life histories of myeloproliferative neoplasms inferred from phylogenies
Williams, N., Lee, J., Mitchell, E., Moore, L., Baxter, E. J., Hewinson, J., Dawson, K. J., Menzies, A., Godfrey, A. L., Green, A. R., et al. (2022) · Nature · doi:10.1038/s41586-021-04312-6 · Cited by 285
Inflammation and myeloproliferative neoplasms
Lussana, F., & Rambaldi, A. (2017) · Journal of Autoimmunity · doi:10.1016/j.jaut.2017.06.010 · Cited by 136
Inflammatory Pathophysiology as a Contributor to Myeloproliferative Neoplasms
Fisher, D. A. C., Fowles, J. S., Zhou, A., & Oh, S. T. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.683401 · Cited by 115
Metadata
- Authors
- Fleischman, A. G.
- Venue
- Mediators of Inflammation
- Publisher
- Wiley
- Published
- 2015-01
- Volume
- 2015
- Issue
- 1
- ISSN
- 0962-9351
- 1466-1861
- PMC
- PMC4619974
- Cited by
- 53
- References
- 62
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.